Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Lantos Technologies Inc.

Nov 2010
In Massachusetts, Lantos Technologies Inc. of Cambridge has announced that it has closed on a $1.6 million deal to develop its 3-D ear canal imaging technology. Braintree-based Catalyst Health Ventures led the round, which was joined by Boston-based investors Excel Venture Management and Mass Medical Angels. Lantos’ technology provides minimally invasive digital mapping of the human ear canal, enabling the development of custom-fit audio devices such as hearing aids, earphones and noise-canceling devices. Dubbed emission reabsorption laser-induced fluorescence, the technology is a new method of 3-D image capture; the intra-aural scanner will be its first application in the medical field.

The emission of light or other electromagnetic radiation of longer wavelengths by a substance as a result of the absorption of some other radiation of shorter wavelengths, provided the emission continues only as long as the stimulus producing it is maintained. In other words, fluorescence is the luminescence that persists for less than about 10-8 s after excitation.
3-D ear canal imaging3-D image captureaudioBiophotonicsBusinessCatalyst Health Venturesdigital mappingear canalearphonesExcel Venture Managementfluorescencehearing aidshuman ear canalimagingintra-aural scannerLantos Technologies Inc.Mass Medical Angelsmedicalnoise-cancelling devicesRapidScanreabsorption laser-induced fluorescence

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.